Parmar, M. T. (2026) “Low Beta Is Not Low Risk: Evidence and Investor Implications from Five Indian Pharmaceutical Stocks, 2021–2025”, International Journal of Engineering and Management Research, 16(3), pp. 113–125. doi: 10.31033/IJEMR/16.3.2026.1941.